These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 13838534)

  • 1. [On the problem of experimental models in the search for antineoplastic agents].
    TIUNOV LA
    Vopr Onkol; 1960; 6():37-8. PubMed ID: 13838534
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE SPECTRUM OF ANTI-HEPATOMA AGENTS].
    SATO H
    Saishin Igaku; 1965 Apr; 20():1000-3. PubMed ID: 14317153
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leukemia P 1534 as an experimental model for the study of antineoplastic drugs].
    Radzikowski C
    Postepy Hig Med Dosw; 1965; 19(5):647-82. PubMed ID: 5324386
    [No Abstract]   [Full Text] [Related]  

  • 4. [APROPOS OF SCREENING AND PHARMACOLOGICAL CHARACTERIZATION OF CANCEROTOXIC SUBSTANCES].
    BROCK N; SCHNEIDER B
    Antibiot Chemother; 1964; 12():391-405. PubMed ID: 14262404
    [No Abstract]   [Full Text] [Related]  

  • 5. Graph theoretical approach to structure-activity studies: search for optimal antitumor compounds.
    Randić M
    Prog Clin Biol Res; 1985; 172A():309-18. PubMed ID: 3991679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [BIOCHEMICAL MECHANISMS OF ACTION OF ANTINEOPLASTIC ANTIBIOTICS IN CONNECTION WITH THE PROBLEM OF THE SEARCH FOR NEW ACTIVE AGENTS].
    GAUZE GF
    Vestn Akad Med Nauk SSSR; 1965; 20():46-52. PubMed ID: 14302292
    [No Abstract]   [Full Text] [Related]  

  • 7. Vinca alkaloids vs. taxanes as therapy in lymphoid malignancies: do our experimental models obscure our understanding of how these drugs really work?
    Lerner A; Andrea N
    Cancer Invest; 2005; 23(1):100-2. PubMed ID: 15779874
    [No Abstract]   [Full Text] [Related]  

  • 8. Calculated resistance in cancer.
    Sawyers CL
    Nat Med; 2005 Aug; 11(8):824-5. PubMed ID: 16079872
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental models for the development of new medical treatments in prostate cancer.
    Chauchereau A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S200-14. PubMed ID: 21943976
    [No Abstract]   [Full Text] [Related]  

  • 10. Binding free energy of selected anticancer compounds to DNA--theoretical calculations.
    Baginski M; Polucci P; Antonini I; Martelli S
    J Mol Model; 2002 Jan; 8(1):24-32. PubMed ID: 12111399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the selection of chemotherapeutic agents.
    Hryniuk WM; Bertino JR
    Adv Intern Med; 1969; 15():267-97. PubMed ID: 4908621
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of mathematical modelling for calculating the optimal plan for administration of the antineoplastic agent thiophosphamide].
    Borisova OV; Korol' VI; Kulik GI; Petunin IuI; Sosnovskiĭ AA; Likhovid AP
    Dokl Akad Nauk SSSR; 1992; 322(2):410-4. PubMed ID: 1600860
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction. Neutropenia risk models in oncology.
    Lyman GH
    Oncology (Williston Park); 2003 Nov; 17(11 Suppl 11):5-7. PubMed ID: 14682112
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of the A.S.I.A. model to activities of manipulation of antineoplastic drugs].
    Placentino RA; Cesarini L; Sacco A; Magnavita N
    G Ital Med Lav Ergon; 2003; 25 Suppl(3):178-9. PubMed ID: 14979138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast as a model system for anticancer drug discovery.
    Simon JA; Bedalov A
    Nat Rev Cancer; 2004 Jun; 4(6):481-92. PubMed ID: 15170450
    [No Abstract]   [Full Text] [Related]  

  • 16. [The doubling time of bronchial cancers].
    Israel L; Chahinian P
    Rev Fr Etud Clin Biol; 1969; 14(7):703-10. PubMed ID: 4901305
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dose factors/time factors in chemotherapy].
    Philip T; Bouffet E; Biron P; Brunat-Mentigny M
    Bull Cancer; 1989; 76(9):979-94. PubMed ID: 2695186
    [No Abstract]   [Full Text] [Related]  

  • 18. [Design of new antineoplastic drugs].
    Smeyers YG
    Rev Esp Oncol; 1985; 32(2):227-36. PubMed ID: 3843457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of new knowledge to the effective administration of anticancer agents.
    Nichol CA
    Cancer Res; 1969 Dec; 29(12):2469-70. PubMed ID: 5369693
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancer chemotherapy--a nursing model.
    Levine ME
    Nurs Clin North Am; 1978 Jun; 13(2):271-80. PubMed ID: 248743
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.